TY - JOUR
T1 - The association between aberrant salience and psychotic experiences in general population twins, and genetic vulnerability as a modifier
AU - Drukker, Marjan
AU - Todor, Tatvan
AU - Bongaarts, Jelle
AU - Broggi, Eleonora
AU - Kelkar, Mihika
AU - Wigglesworth, Thomas
AU - Verhiel, Kayle
AU - van Leeuwen, Karel
AU - Koster, Meinte
AU - Derom, Catherine
AU - Thiery, Evert
AU - De Hert, Marc
AU - Menne-Lothmann, Claudia
AU - Decoster, Jeroen
AU - Collip, Dina
AU - van Winkel, Ruud
AU - Jacobs, Nele
AU - Guloksuz, Sinan
AU - Rutten, Bart
AU - van Os, Jim
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10/26
Y1 - 2024/10/26
N2 - Background: Previous studies assessing the hypothesis that the construct of ‘aberrant salience’ is associated with psychosis and psychotic symptoms showed conflicting results. For this reason, the association between measures to index aberrant salience and subclinical psychotic symptoms in a general population sample was analysed. In addition, genetic vulnerability was added to the analysis as a modifier to test the hypothesis that modification by genetic vulnerability may explain variability in the results. Methods: The TwinssCan project obtained data from general population twins (N = 887). CAPE (Community Assessment of Psychic Experience) scores were used to index psychotic experiences. Aberrant salience was assessed with white noise task and ambiguous situations task. Results: Measures of aberrant salience were not associated with psychotic experiences, nor was there evidence for an interaction with genetic predisposition in this association (Z = 1.08, p = 0.282). Conclusions: Various studies including the present could not replicate the association between aberrant salience and psychotic experiences in general population samples. The conflicting findings might be explained by moderation by genetic vulnerability, but results are inconsistent. If there was evidence for a main effect or interaction, this was in the positive symptom scale only. On the other hand, the association was more robust in so-called ‘ultra-high risk’ patients and first episode psychosis patients. Thus, this association may represent a state-dependent association, present only at the more severe end of the psychosis spectrum.
AB - Background: Previous studies assessing the hypothesis that the construct of ‘aberrant salience’ is associated with psychosis and psychotic symptoms showed conflicting results. For this reason, the association between measures to index aberrant salience and subclinical psychotic symptoms in a general population sample was analysed. In addition, genetic vulnerability was added to the analysis as a modifier to test the hypothesis that modification by genetic vulnerability may explain variability in the results. Methods: The TwinssCan project obtained data from general population twins (N = 887). CAPE (Community Assessment of Psychic Experience) scores were used to index psychotic experiences. Aberrant salience was assessed with white noise task and ambiguous situations task. Results: Measures of aberrant salience were not associated with psychotic experiences, nor was there evidence for an interaction with genetic predisposition in this association (Z = 1.08, p = 0.282). Conclusions: Various studies including the present could not replicate the association between aberrant salience and psychotic experiences in general population samples. The conflicting findings might be explained by moderation by genetic vulnerability, but results are inconsistent. If there was evidence for a main effect or interaction, this was in the positive symptom scale only. On the other hand, the association was more robust in so-called ‘ultra-high risk’ patients and first episode psychosis patients. Thus, this association may represent a state-dependent association, present only at the more severe end of the psychosis spectrum.
KW - Aberrant salience
KW - Genetic vulnerability
KW - Subclinical psychotic symptoms
UR - http://www.scopus.com/inward/record.url?scp=85207829393&partnerID=8YFLogxK
U2 - 10.1186/s12888-024-06176-2
DO - 10.1186/s12888-024-06176-2
M3 - Article
C2 - 39462331
AN - SCOPUS:85207829393
SN - 1471-244X
VL - 24
JO - BMC Psychiatry
JF - BMC Psychiatry
IS - 1
M1 - 736
ER -